Joar Guterstam

870 total citations
26 papers, 601 citations indexed

About

Joar Guterstam is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Joar Guterstam has authored 26 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 7 papers in Cognitive Neuroscience and 7 papers in Psychiatry and Mental health. Recurrent topics in Joar Guterstam's work include Neurotransmitter Receptor Influence on Behavior (9 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Substance Abuse Treatment and Outcomes (5 papers). Joar Guterstam is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (9 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Substance Abuse Treatment and Outcomes (5 papers). Joar Guterstam collaborates with scholars based in Sweden, Norway and United States. Joar Guterstam's co-authors include Johan Franck, Nitya Jayaram‐Lindström, Maija Konstenius, Olof Beck, Björn Philips, Eline Borger Rognli, Else‐Marie Løberg, Lars Tanum, Jørgen G. Bramness and Bo Söderpalm and has published in prestigious journals such as PLoS ONE, Psychological Medicine and Psychopharmacology.

In The Last Decade

Joar Guterstam

23 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joar Guterstam Sweden 10 229 227 147 119 107 26 601
Begoña Gonzalvo Spain 14 308 1.3× 231 1.0× 225 1.5× 100 0.8× 118 1.1× 30 680
Rasmon Kalayasiri Thailand 17 218 1.0× 146 0.6× 150 1.0× 35 0.3× 135 1.3× 40 588
H. Walter Austria 10 218 1.0× 148 0.7× 218 1.5× 106 0.9× 78 0.7× 31 733
Jennifer G. Plebani United States 10 187 0.8× 67 0.3× 245 1.7× 53 0.4× 86 0.8× 16 511
Kenneth M. Dürsteler‐MacFarland Switzerland 17 156 0.7× 81 0.4× 216 1.5× 54 0.5× 89 0.8× 37 604
Thorne Sparkman United States 12 471 2.1× 204 0.9× 247 1.7× 90 0.8× 193 1.8× 15 802
Christoph Klawe Germany 13 218 1.0× 132 0.6× 152 1.0× 68 0.6× 174 1.6× 21 725
Atapol Sughondhabirom Thailand 14 153 0.7× 120 0.5× 58 0.4× 38 0.3× 78 0.7× 24 525
Aida Cuenca‐Royo Spain 14 92 0.4× 81 0.4× 84 0.6× 120 1.0× 122 1.1× 29 671
P.J. Geerlings Netherlands 10 234 1.0× 86 0.4× 279 1.9× 79 0.7× 69 0.6× 12 708

Countries citing papers authored by Joar Guterstam

Since Specialization
Citations

This map shows the geographic impact of Joar Guterstam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joar Guterstam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joar Guterstam more than expected).

Fields of papers citing papers by Joar Guterstam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joar Guterstam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joar Guterstam. The network helps show where Joar Guterstam may publish in the future.

Co-authorship network of co-authors of Joar Guterstam

This figure shows the co-authorship network connecting the top 25 collaborators of Joar Guterstam. A scholar is included among the top collaborators of Joar Guterstam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joar Guterstam. Joar Guterstam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Söderpalm, Bo, Helga Lidö, Johan Franck, et al.. (2025). Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trial. The Lancet Regional Health - Europe. 54. 101310–101310.
3.
Kaboodvand, Neda, et al.. (2024). Neural correlates of impulsivity in amphetamine use disorder. Psychiatry Research Neuroimaging. 343. 111860–111860. 4 indexed citations
4.
Hammarberg, Anders, et al.. (2024). Phosphatidylethanol as an outcome measure in treatment aimed at controlled drinking. Alcohol and Alcoholism. 59(6). 2 indexed citations
5.
Guterstam, Joar, et al.. (2024). A multicomponent LC-MS/MS method for drugs of abuse testing using volumetric DBS and a clinical evaluation by comparison with urine. Journal of Pharmaceutical and Biomedical Analysis. 243. 116075–116075. 4 indexed citations
6.
Guterstam, Joar, et al.. (2024). Validation and application of an automated multitarget LC-MS/MS method for drugs of abuse testing using exhaled breath as specimen. Journal of Chromatography B. 1240. 124142–124142. 1 indexed citations
7.
Pettersson, Emma, Ellenor Mittendorfer‐Rutz, Joar Guterstam, et al.. (2023). The risk and development of work disability among individuals with gambling disorder: a longitudinal case–cohort study in Sweden. Psychological Medicine. 54(7). 1391–1402. 3 indexed citations
8.
Metrebian, Nicola, Ben Carter, Rebecca McDonald, et al.. (2023). A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS. BMC Public Health. 23(1). 1608–1608. 2 indexed citations
10.
Guterstam, Joar, Nitya Jayaram‐Lindström, Jonathan Berrebi, et al.. (2022). The Hypothesis of Subliminal Cue Reactivity in Addiction Revisited: An fMRI Study. European Addiction Research. 28(3). 210–219. 1 indexed citations
12.
Steensland, Pia, et al.. (2019). Effects of the monoamine stabilizer (-)OSU6162 on cognitive function in alcohol dependence. Psychopharmacology. 237(1). 69–82. 3 indexed citations
13.
Guterstam, Joar, Nitya Jayaram‐Lindström, Jonathan Berrebi, et al.. (2018). Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study. Drug and Alcohol Dependence. 191. 91–97. 10 indexed citations
14.
Jayaram‐Lindström, Nitya, Joar Guterstam, Jenny Häggkvist, et al.. (2017). Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study. Translational Psychiatry. 7(4). e1104–e1104. 14 indexed citations
15.
Walther, Lisa, Elin Löf, Therése Hansson, et al.. (2015). Phosphatidylethanol is Superior to Carbohydrate‐Deficient Transferrin and γ‐Glutamyltransferase as an Alcohol Marker and is a Reliable Estimate of Alcohol Consumption Level. Alcoholism Clinical and Experimental Research. 39(11). 2200–2208. 82 indexed citations
16.
Steensland, Pia, Joar Guterstam, Olof Beck, et al.. (2015). The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study. European Neuropsychopharmacology. 25(12). 2240–2251. 29 indexed citations
17.
Konstenius, Maija, Nitya Jayaram‐Lindström, Joar Guterstam, et al.. (2013). 1128 – Methylphenidate For Adhd In Adults With Substance Dependence: a 24-week Randomized Placebo-controlled Trial. European Psychiatry. 28(S1). 1 indexed citations
18.
Guterstam, Joar, Nitya Jayaram‐Lindström, Simon Červenka, et al.. (2012). Effects of amphetamine on the human brain opioid system – a positron emission tomography study. The International Journal of Neuropsychopharmacology. 16(4). 763–769. 20 indexed citations
19.
Bramness, Jørgen G., Joar Guterstam, Eline Borger Rognli, et al.. (2012). Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?. BMC Psychiatry. 12(1). 221–221. 163 indexed citations
20.
Guterstam, Joar, et al.. (2012). Alcohol Dependence Associated with Increased Utilitarian Moral Judgment: A Case Control Study. PLoS ONE. 7(6). e39882–e39882. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026